Skip to content
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
COVID-19
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
CHEN LAB
Dai Lab
Gelfand Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
NEWS
DONATE
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
COVID-19
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
CHEN LAB
Dai Lab
Gelfand Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
NEWS
DONATE
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
COVID-19
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
CHEN LAB
Dai Lab
Gelfand Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
NEWS
DONATE
ABOUT
MISSION
Advisors
Management Team
Principal Investigators
collaborators
COVID-19
TECHNOLOGIES
Infectious Disease
Immuno-oncology
Regenerative Medicine & Immunotherapy
High Dimensional Immunology
LABORATORIES
CHEN LAB
Dai Lab
Gelfand Lab
Poznansky Lab
Reeves Lab
Sîrbulescu Lab
NEWS
DONATE
Production, deployment among challenges when COVID-19 vaccine ready
Posted on
July 24, 2020
View Via Yahoo Finance
Facebook
Twitter
Recommended Posts
COVID vaccines: Are you ‘primed’ for the best outcome?
No early end to COVID-19: A new strain in any nation threatens us all.
“I Really Love Type 1 Diabetes Research, and I’m Not Going Back”
Congratulations to David Alagpulinsa
